FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely methotrexate (as methotrexate sodium) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methotrexate 10 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methotrexate 5 milligram/1 each conventional release oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methotrexate 7.5 milligram/1 each conventional release oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methotrexate 15 milligram/1 each conventional release oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing mercaptopurine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing mercaptopurine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only mercaptopurine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mercaptopurine 50 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only masoprocol (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing masoprocol Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only ixabepilone (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ixabepilone 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ixabepilone 45 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing ixabepilone in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only ixabepilone in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing ixabepilone Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing irinotecan Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing irinotecan in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only irinotecan liposome (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only irinotecan in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only irinotecan liposome in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only inotuzumab ozogamicin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Inotuzumab ozogamicin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing inotuzumab ozogamicin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing inotuzumab ozogamicin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing temozolomide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Temozolomide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only temozolomide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing temozolomide in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only temozolomide in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely temozolomide 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely temozolomide 5 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely temozolomide 20 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely temozolomide 100 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely temozolomide 250 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely temozolomide 140 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely temozolomide 180 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing temozolomide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Temsirolimus Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing temsirolimus Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing topotecan in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing topotecan in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing topotecan Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Topotecan Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only topotecan in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only topotecan in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely topotecan (as topotecan hydrochloride) 250 microgram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing tegafur and uracil Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tegafur 100 milligram and uracil 224 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only tegafur (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tegafur + Uracil Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only tegafur and uracil in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing tegafur Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing tegafur and uracil in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Talimogene laherparepvec Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only talimogene laherparepvec in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing talimogene laherparepvec Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing talimogene laherparepvec in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing teniposide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only teniposide (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely teniposide 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing teniposide in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only teniposide in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing thiotepa Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Thiotepa Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only thiotepa in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing thiotepa in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing tioguanine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing tioguanine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tioguanine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only tioguanine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tioguanine 40 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing lomustine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only lomustine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Lomustine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely lomustine 40 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely lomustine 10 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely lomustine 100 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing lomustine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing trastuzumab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Trastuzumab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only trastuzumab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely trastuzumab 440 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing trastuzumab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing osimertinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Osimertinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only enasidenib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only enasidenib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing enasidenib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing enasidenib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 10 of 26 Next End

This concept is not in any reference sets

Back to Start